Use of Anticoagulant Drug After Aortic Valve Replacement Lowers Mortality Risk Dec. 7, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...
Hypothesis: MI accelerates the progression of bioprosthetic valve degeneration. Methods: A retrospective cohort analysis of patients who underwent a bioprosthetic aortic or mitral valve replacement at ...
Valve has announced the Steam Deck OLED: White Edition. This new version of the handheld PC launches on 18th November, but if you want one, be warned: only a limited number will be available ...
Nat Clin Pract Cardiovasc Med. 2008;5(12):764-765. We believe that strategies to avoid or reduce the severity of PPM should be individualized and take into account multiple variables, such as ...
Notable history included aortic regurgitation due to bicuspid aortic valve resulting in subcoronary implantation of a 27 mm Medtronic Freestyle stentless porcine bioprosthesis 20 years prior to ...
A variety of forms of mechanical circulatory support are available for children with cardiopulmonary dysfunction refractory to conventional management. These devices require extensive resources ...
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...
dhm.mhn.de Objective: It is presumed that patient-prosthesis mismatch (PPM) influences morbidity and mortality after aortic valve replacement (AVR). The aim of our study was to determine the impact of ...
In this retrospective cohort of patients with atrial fibrillation (AF) who underwent transcatheter aortic valve replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback